Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

February 01, 2003; Volume 30,Issue 2
  • You have access
    Retinoids and rexinoids for the 21st century: a brave new world for arthritis.
    Constance E Brinckerhoff and Michael B Sporn
    The Journal of Rheumatology February 1 2003, 30 (2) 211-213;
  • You have access
    Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome.
    Ronald A Asherson and Yehuda Shoenfeld
    The Journal of Rheumatology February 1 2003, 30 (2) 214-219;
  • You have access
    Expression of lactoferrin on neutrophil granulocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis.
    Domenico Caccavo, Pierluigi Garzia, Gian Domenico Sebastiani, Giovanni Maria Ferri, Sara Galluzzo, Marta Vadacca, Amelia Rigon, Antonella Afeltra and Antonio Amoroso
    The Journal of Rheumatology February 1 2003, 30 (2) 220-224;
  • You have access
    Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis.
    Stanley B Cohen, J Michael Woolley, Wing Chan and Anakinra 960180 Study Group
    The Journal of Rheumatology February 1 2003, 30 (2) 225-231;
  • You have access
    Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis.
    Alfons A den Broeder, Geert J A Wanten, Wim J G Oyen, Ton Naber, Piet L C M van Riel and Pilar Barrera
    The Journal of Rheumatology February 1 2003, 30 (2) 232-237;
  • You have access
    Modified Larsen scoring of digitized radiographs in rheumatoid arthritis.
    Steven A Young-Min, Sanjeev Shakhapur, Nicky Marshall, Ian Griffiths, Tim Cawston and Andrew Grainger
    The Journal of Rheumatology February 1 2003, 30 (2) 238-240;
  • You have access
    The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Eliza F Chakravarty, Deanna Sanchez-Yamamoto and Thomas M Bush
    The Journal of Rheumatology February 1 2003, 30 (2) 241-246;
  • You have access
    Effect of NOS2 gene deficiency on the development of autoantibody mediated arthritis and subsequent articular cartilage degeneration.
    Hisayoshi Kato, Keiichiro Nishida, Aki Yoshida, Itsuro Takada, Cherie McCown, Masatsugu Matsuo, Takuro Murakami and Hajime Inoue
    The Journal of Rheumatology February 1 2003, 30 (2) 247-255;
  • You have access
    Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.
    Janette Furuzawa-Carballeda, Antonio R Cabral, Martín Zapata-Zuñiga and Jorge Alcocer-Varela
    The Journal of Rheumatology February 1 2003, 30 (2) 256-259;
  • You have access
    Angiopoietins, growth factors, and vascular morphology in early arthritis.
    Ursula Fearon, Konstantina Griosios, Alexander Fraser, Richard Reece, Paul Emery, Pamela F Jones and Douglas J Veale
    The Journal of Rheumatology February 1 2003, 30 (2) 260-268;
  • You have access
    Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Daniela Vogl, Werner Falk, Monika Dorner, Jürgen Schölmerich and Rainer H Straub
    The Journal of Rheumatology February 1 2003, 30 (2) 269-275;
  • You have access
    Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoimmunity.
    Patricia A Fraser, Wei-Zi Ding, Mehrdad Mohseni, Edward L Treadwell, Mary Anne Dooley, E William St Clair, Gary S Gilkeson and Glinda S Cooper
    The Journal of Rheumatology February 1 2003, 30 (2) 276-282;
  • You have access
    Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects.
    Roald Omdal, Knut Waterloo, Wenche Koldingsnes, Gunnar Husby and Svein Ivar Mellgren
    The Journal of Rheumatology February 1 2003, 30 (2) 283-287;
  • You have access
    Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities.
    Ian N Bruce, Dafna D Gladman, Dominique Ibañez and Murray B Urowitz
    The Journal of Rheumatology February 1 2003, 30 (2) 288-291;
  • You have access
    Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
    Hermine I Brunner, Brian M Feldman, Murray B Urowitz and Dafna D Gladman
    The Journal of Rheumatology February 1 2003, 30 (2) 292-297;
  • You have access
    Homocysteine plasma concentration is related to severity of lung impairment in scleroderma.
    Paola Caramaschi, Nicola Martinelli, Domenico Biasi, Antonio Carletto, Giovanni Faccini, Alessandro Volpe, Marcello Ferrari, Cinzia Scambi and Lisa Maria Bambara
    The Journal of Rheumatology February 1 2003, 30 (2) 298-304;
  • You have access
    NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis.
    Bill Newman, Laurence A Rubin and Katherine A Siminovitch
    The Journal of Rheumatology February 1 2003, 30 (2) 305-307;
  • You have access
    Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation.
    Ruth Gershoni-Baruch, Riva Brik, Merav Lidar, Marwan Shinawi and Avi Livneh
    The Journal of Rheumatology February 1 2003, 30 (2) 308-312;
  • You have access
    Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
    Sedat Kiraz, Ihsan Ertenli, M Akif Oztürk, Ibrahim C Haznedaroglu, Meral Calgüneri, Enver Atalar, Zeynep Ozbalkan, Serafettin Kirazli and Ismail Celik
    The Journal of Rheumatology February 1 2003, 30 (2) 313-315;
  • You have access
    Predictors of longterm outcome in ankylosing spondylitis.
    Michele F Doran, Sinead Brophy, Kirsten MacKay, Gordon Taylor and Andrei Calin
    The Journal of Rheumatology February 1 2003, 30 (2) 316-320;
  • You have access
    HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis.
    Chung T Chou, Jia M Chen, Chang M Hsu and Shu J Chen
    The Journal of Rheumatology February 1 2003, 30 (2) 321-325;
  • You have access
    Intermittent hydrostatic pressure inhibits shear stress-induced nitric oxide release in human osteoarthritic chondrocytes in vitro.
    Mel S Lee, Michael C D Trindade, Takashi Ikenoue, David J Schurman, Stuart B Goodman and R Lane Smith
    The Journal of Rheumatology February 1 2003, 30 (2) 326-328;
  • You have access
    X-ray technologists' reproducibility from automated measurements of the medial tibiofemoral joint space width in knee osteoarthritis for a multicenter, multinational clinical trial.
    J Chris Buckland-Wright, Charles F Bird, Cathy A Ritter-Hrncirik, Gary A Cline, Carol Tonkin, Thomas N Hangartner, Rupert J Ward, Joan M Meyer and Michael P Meredith
    The Journal of Rheumatology February 1 2003, 30 (2) 329-338;
  • You have access
    Blood-induced joint damage: longterm effects in vitro and in vivo.
    Michel Hooiveld, Goris Roosendaal, Marieke Vianen, Marijke van den Berg, Johannes Bijlsma and Floris Lafeber
    The Journal of Rheumatology February 1 2003, 30 (2) 339-344;
  • You have access
    Enhanced lipid peroxidation in synoviocytes from patients with osteoarthritis.
    Brunella Grigolo, Livia Roseti, Mauro Fiorini and Andrea Facchini
    The Journal of Rheumatology February 1 2003, 30 (2) 345-347;
  • You have access
    Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head.
    Valérie Gangji, Jean-Philippe Hauzeur, André Schoutens, Maurice Hinsenkamp, Thierry Appelboom and Dominique Egrise
    The Journal of Rheumatology February 1 2003, 30 (2) 348-351;
  • You have access
    Ultrasonographic evaluation of pes anserinus tendino-bursitis in patients with type 2 diabetes mellitus.
    Zeliha Unlu, Bilgin Ozmen, Serdar Tarhan, Sibel Boyvoda and Cihan Goktan
    The Journal of Rheumatology February 1 2003, 30 (2) 352-354;
  • You have access
    Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis.
    Blake C Beehler, Yong-Jiang Hei, Simon Chen, John A Lupisella, Jacek Ostrowski, John E Starrett, David Tortolani, Kenneth M Tramposch and Peter R Reczek
    The Journal of Rheumatology February 1 2003, 30 (2) 355-363;
  • You have access
    Function of beta-adrenergic receptors on mononuclear cells in female patients with fibromyalgia.
    Kenji Maekawa, Cheryl Twe, Ana Lotaif, Francesco Chiappelli and Glenn T Clark
    The Journal of Rheumatology February 1 2003, 30 (2) 364-368;
  • You have access
    Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease.
    Frederick Wolfe
    The Journal of Rheumatology February 1 2003, 30 (2) 369-378;
  • You have access
    Translation and cultural adaptation of quality of life questionnaires: an evaluation of methodology.
    Dircilene da Mota Falcão, Rozana Mesquita Ciconelli and Marcos Bosi Ferraz
    The Journal of Rheumatology February 1 2003, 30 (2) 379-385;
  • You have access
    Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
    Berit FlatØ, Gunhild Lien, Anna Smerdel, Odd Vinje, Knut Dale, Virginia Johnston, Dag SØrskaar, TorbjØrn Moum, Rafal Ploski and Øystein FØrre
    The Journal of Rheumatology February 1 2003, 30 (2) 386-393;
  • You have access
    Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.
    Suzanne L Bowyer, Philip A Roettcher, Gloria C Higgins, Barbara Adams, Linda K Myers, Carol Wallace, Robert Rennebohm, Terry L Moore, Peri H Pepmueller, Charles Spencer, Linda Wagner-Weiner, Egla Rabinovich, Murray Passo, Daniel J Lovell, Deborah McCurdy, Lawrence Zemel, Kenneth N Schikler, Ilona Szer, Paul Kurtin and Carol Lindsley
    The Journal of Rheumatology February 1 2003, 30 (2) 394-400;
  • You have access
    Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Athimalaipet V Ramanan and Rayfel Schneider
    The Journal of Rheumatology February 1 2003, 30 (2) 401-403;
  • You have access
    Salazosulfapyridine-induced remission of Felty's syndrome along with significant reduction in neutrophil-bound immunoglobulin G.
    Keiko Ishikawa, Yoshito Tsukada, Shigeo Tamura, Yoriaki Kaneko, Takashi Kuroiwa, Kazue Ueki, Tomoko Sugiura and Yoshihisa Nojima
    The Journal of Rheumatology February 1 2003, 30 (2) 404-406;
  • You have access
    Infliximab in the treatment of an HIV positive patient with Reiter's syndrome.
    Norman Gaylis
    The Journal of Rheumatology February 1 2003, 30 (2) 407-411;
  • You have access
    B cell loss leading to remission in severe systemic lupus erythematosus.
    Teresa K Tarrant, D Hugh Frazer, James P Aya-Ay and Dhavalkumar D Patel
    The Journal of Rheumatology February 1 2003, 30 (2) 412-414;
  • You have access
    Chronic arsenic poisoning mimicking Gottron's rash.
    Anupam Wakhlu, Amita Aggarwal and Ramnath Misra
    The Journal of Rheumatology February 1 2003, 30 (2) 415-416;
  • You have access
    Gout related upper limb cellulitis: an ultrasound study.
    Richard J Wakefield, Paul Emery and Colin Pease
    The Journal of Rheumatology February 1 2003, 30 (2) 417-419;
  • You have access
    Transforming growth factor-beta levels in synovial fluid of osteoarthritis with or without calcium pyrophosphate dihydrate crystals.
    Leonard Punzi, Francesca Oliviero and Roberta Ramonda
    The Journal of Rheumatology February 1 2003, 30 (2) 420;
  • You have access
    Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib.
    Bernard Bannwarth, Philippe Ravaud and Maxine Dougados
    The Journal of Rheumatology February 1 2003, 30 (2) 421-422;
  • You have access
    Diabetes mellitus type 1 and stiff hips.
    Andrew M Ropp and James M Strosberg
    The Journal of Rheumatology February 1 2003, 30 (2) 422-423;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 30, Issue 2
1 Feb 2003
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • Most Cited
Loading
  • Management of Calcinosis Cutis in Rheumatic Diseases
  • What Is Allopurinol Failure and What Should We Do About It?
  • Autoinflammatory Diseases: A Review
  • Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
  • Rheumatoid Arthritis: The Continuum of Disease and Strategies for Prediction, Early Intervention, and Prevention
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire